Targeting BMPR-II in pulmonary arterial hypertension: a case of Hercules versus the Hydra?

M Martin VandenBroek; Sofia I Skebo; Mark L Ormiston

doi:10.1080/14728222.2022.2168188

Targeting BMPR-II in pulmonary arterial hypertension: a case of Hercules versus the Hydra?

Expert Opin Ther Targets. 2022 Dec;26(12):1027-1030. doi: 10.1080/14728222.2022.2168188. Epub 2023 Jan 18.

Authors

M Martin VandenBroek¹, Sofia I Skebo², Mark L Ormiston^{1

3}

Affiliations

¹ Department of Medicine, Queen's University, Kingston, K7L, Canada.
² Department of Biology, Queen's University, Kingston, K7L, Canada.
³ Departments of Biomedical and Molecular Sciences and Surgery, Queen's University, Kingston, K7L, Canada.

PMID: 36638064
DOI: 10.1080/14728222.2022.2168188

No abstract available

Keywords: BMPR2; Pulmonary arterial hypertension; bone morphogenetic protein 9; ligand trap; type II bone morphogenetic protein receptor (BMPR-II).

Publication types

Case Reports
Editorial

MeSH terms

Animals
Bone Morphogenetic Protein Receptors, Type II
Humans
Hydra*
Hypertension, Pulmonary* / drug therapy
Lung
Pulmonary Arterial Hypertension*

Substances

Bone Morphogenetic Protein Receptors, Type II